title: Is the third component of metabolic syndrome really predictive of outcomes in type 2 diabetic patients?
authors.affiliation: Department of Critical Care Medicine and Surgery, Unit of Gerontology and Geriatrics, University of Florence and Azienda Ospedaliera Careggi, Via delle Oblate 4, 50134 Florence, Italy.
authors.forename: Matteo
authors.initials: M
authors.lastname: Monami
authors.forename: Lorella
authors.initials: L
authors.lastname: Lambertucci
authors.forename: Andrea
authors.initials: A
authors.lastname: Ungar
authors.forename: Maria
authors.initials: M
authors.lastname: Pieri
authors.forename: Giulio
authors.initials: G
authors.lastname: Masotti
authors.forename: Niccolò
authors.initials: N
authors.lastname: Marchionni
authors.forename: Edoardo
authors.initials: E
authors.lastname: Mannucci
mesh_terms: D000368:Aged; D001794:Blood Pressure; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis* / Q000401:mortality* / Q000628:therapy; D005260:Female; D006801:Humans; D006943:Hyperglycemia / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D015228:Hypertriglyceridemia / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D007333:Insulin Resistance; D008297:Male; D024821:Metabolic Syndrome / Q000175:diagnosis* / Q000401:mortality* / Q000628:therapy; D008875:Middle Aged; D009017:Morbidity; D011237:Predictive Value of Tests; D012042:Registries; D012307:Risk Factors